This study presents an overview and a short critical review of patented antibiofilm technologies. Patent information was used to determine scenarios that could be used by decision-makers or business intelligence. The study found that academia, mainly from the USA, has been applying for the most patents since 1997. Based on the S-curve analysis, the maturity of this technology sector is emerging. The technological specialization for the 10 most prominent patent applicants and state-of-the-art antibiofilm patents are presented.